President Dr. José Luis Leiva Pons Has Taken Office

SOLACI has a new president! Dr. José Luis Leiva Pons (Mexico) has taken over the reins of the Latin American Society of Interventional Cardiology for the next two years, succeeding Dr. Ricardo Lluberas (Uruguay), who was president between 2015 and 2017.

Dr. José Luis Leiva Pons
Dr. José Luis Leiva Pons will be SOLACI’s President until 2019.

Originally from the city of San Luis Potosí (Mexico), Leiva Pons is not a stranger to SOLACI. In fact, he was one of the founders. He has participated as Secretary and Vice-President to Lluberas administration: “After quite some time, we meet again with SOLACI (…) I never imagined things would turn out this way, from Secretary to President”, stated Pons during the closing ceremony of SOLACI-CACI 2017, celebrated at the Hilton Hotel in Buenos Aires.

 

In his first statement as President, Leiva Pons thanked Lluberas (“we’ve cultivated a deep friendship, not just from President to Vice-President”) and stated his objectives from here on out: “SOLACI must keep fostering regional participation and integration of our specialty, encouraging all Latin America to be together in this that represents us so well”, he announced.

 

In addition, he pointed out the importance of all areas that make SOLACI, such as the Regional Sessions (conducted by Drs. Jorge Mayol and Mario Araya), the educational program ProEducar (lead by Drs. Leandro Lasave, Leandro Martínez Riera and Gabriel Maluenda), SOLACI Aid (run by Dr. Marcelo Halac) and the web page (Dr. José Álvarez).

Dr. Ricardo Lluberas
Former SOLACI President  Ricardo Lluberas, during the closing ceremony at SOLACI-CACI 2017.

On the other hand, he expressed he will work to “strengthen relationships with the industry and with the international scientific societies, such as TCT, PCR, SCAI, The Cleveland Clinic Foundation, among others”.

 

“During my administration, I shall not seek the ‘what’ but the ‘how to’; that is to say, what we should do to make things happen, to promote the growth of SOLACI and the specialty across the region”, sentenced Leiva Pons, who has also been SOCIME President in the past (Mexican Society of Interventional Cardiology).

 

Even though we have not appointed the one to join Dr. Leiva as Vice-President, we do know Dr. Omar Santaera (Argentina) will continue as Treasurer and Dr. Alfaro Marchena (Panamá) as Secretary.

 

Finally, the brand new SOLACI President announced the next SOLACI-SOCIME to be held next year, will take place in Puebla, México, from August 1 thru 3, 2018: “See you all there. I’m sure we will have a great Congress. Thank you very much!” he concluded.

LO+RL
Dr. José Luis Leiva Pons (left) and Dr. Ricardo Lluberas (right) at SOLACI-CACI 2017 closing ceremony.

 

More articles by this author

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...